---
layout: post
title: "Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Enrollment and Re-Certification of Covered Entities in the 340B Drug Pricing Program, OMB Number 0915-0327-Revision."
date: 2026-02-05 19:01:19 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-23518
original_published: 2022-10-28 00:00:00 +0000
significance: 8.00
---

# Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Enrollment and Re-Certification of Covered Entities in the 340B Drug Pricing Program, OMB Number 0915-0327-Revision.

**Published:** February 05, 2026 19:01 UTC
**Source:** Federal Register
**Original Published:** October 28, 2022 00:00 UTC
**Document Number:** 2022-23518

## Summary

In compliance with of the Paperwork Reduction Act of 1995, HRSA has submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30-day comment period for this notice has closed.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/10/28/2022-23518/agency-information-collection-activities-submission-to-omb-for-review-and-approval-public-comment)
- API: https://www.federalregister.gov/api/v1/documents/2022-23518

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
